The management of endoscopic retrograde cholangiopancreatography-related infections risk: results of an italian survey at regional level
Keywords:
ERCP, duodenoscope associate infections, infection risk, infection preventionAbstract
Background and aim. Among the Endoscopic retrograde cholangiopancreatography (ERCP) adverse events, an increasingly arising problem is the transmission of Multi Drug Resistant (MDR) Bacteria through duodenoscopes. The aim of this survey was to evaluate the current clinical practice of management of ERCP associated infections in Emilia-Romagna, Italy.
Methods. An online survey was developed including 12 questions on management of ERCP associated infections risk. The survey was proposed to all 12 endoscopy centers in Emilia Romagna that perform at least > 200 ERCPs per year.
Results. 11 centers completed the survey (92%). Among all risk factors of ERCP infections, hospitalization in intensive care units, immunosuppressant therapies, and previous MDR infections have achieved a 80 % minimum of concurrence by our respondents. The majority of them did not have a formalized document in their hospital describing categories and risk factors helpful in the detection of patients undergoing ERCP with an high-level infective risk (9/11, 82%).
Most centers (8/11, 72%) do not perform screening in patients at risk of ERCP infections. Post procedural monitoring is performed by 6 of 11 centers (55%).
Conclusion. Our survey showed that, at least at regional level, there is a lack of procedures and protocols related to the management of patients at risk of ERCP infections.
References
1. Adler DG, Baron TH, Davila RE, et al. ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. Gastrointest Endosc. 2005 Jul; 62(1): 1-8. doi: 10.1016/j. gie.2005.04.015.
2. Chandrasekhara V, Khashab MA, Muthusamy VR, et al. Adverse events associated with ERCP. Gastrointest Endosc. 2017 Jan; 85(1): 32-47. doi: 10.1016/j.gie.2016.06.051.
3. Rahman MR, Perisetti A, Coman R, Bansal P, Chhabra R, Goyal H. Duodenoscope Associated Infections: Update on an Emerging Problem.
Dig Dis Sci. 2019 Jun; 1409-18. doi: 10.1007/ s10620-018-5431-7. Epub 2018 Dec 19.
4. Dumonceau JM, Kapral C, Aabakken L, et al. ERCP- related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2020 Feb; 52(2):127-49. doi: 10.1055/a-1075-4080. Epub 2019 Dec 20.
5. Rauwers AW, Voor In ’t Holt AF, Buijs JG, et al. High prevalence rate of digestive tract bacteria in duodenoscopes: a nationwide study. Gut 2018 Sep; 67(9): 1637-45. doi: 10.1136/gutjnl-2017315082. Epub 2018 Apr 10.
6. Alrabaa SF, Nguyen P, Sanderson R, et al. Early identification and control of carbapenemaseproducing Klebsiella pneumoniae, originating from contaminated endoscopic equipment. Am J Infect Control 2013 Jun; 41(6): 562-4. doi: 10.1016/j.ajic.2012.07.008. Epub 2012 Nov 18.
7. Nelson DB, Barkun AN, Block KP, et al. Technology status evaluation report. Transmission of infection by gastrointestinal endoscopy. May 2001. Gastrointest Endosc. 2001 Dec; 54(6): 824-8. doi: 10.1016/s0016-5107(01)70086-7.
8. Kim S, Russell D, Mohamadnejad M, et al. Risk factors associated with the transmission of carbapenem-resistant Enterobacteriaceae via contaminated duodenoscopes. Gastrointest Endosc 2016 Jun; 83(6): 1121-9. doi: 10.1016/j. gie.2016.03.790. Epub 2016 Mar 16.
9. Snyder GM. Introduction to Transmission of Infection: Potential Agents Transmitted by Endoscopy trointest. Endosc Clin N Am. 2020 Oct; 30(4): 611-8. doi: 10.1016/j.giec.2020.05.001. Epub 2020 Jul 20.
10. Suleyman G, Alangaden G, Bardossy AC. The Role of Environmental Contamination in the Transmission of Nosocomial Pathogens and Healthcare-Associated. Curr Infect Dis Rep. 2018 Apr 27; 20(6): 12. https://doi.org/10.1007/ s11908-018-0620-2.
11. Carbonne A, Thiolet JM, Fournier S, et al. Control of a multihospital outbreak of KPCproducing Klebsiella pneumoniae type 2 in France, September to October 2009. Euro Surveill. 2010 Dec 2; 15(48): 19734. doi: 10.2807/ ese.15.48.19734-en.
12. Dortet L, Naas T, Boytchev I, Fortineau N. Endoscopy-associated transmission of carbapenemase-producing Enterobacteriaceae: return of 5 years’ experience. Endoscopy. 2015 Jun; 47(6): 561. doi: 10.1055/s-0034-1392098. Epub 2015 Jun 1.
13. Ranjan P, Das K, Ayyagiri A, Saraswat VA, Choudhuri G. A report of post-ERCP Pseudomonas aeruginosa infection outbreak. Indian J Gastroenterol. 2005 May-Jun; 24(3): 131- 2.
14. Muscarella LF. Risk of transmission of carbapenem-resistant Enterobacteriaceae and related “superbugs” during gastrointestinal endoscopy. World J Gastrointest Endosc. 2014 Oct 16; 6(10): 457-74. doi: 10.4253/wjge.v6.i10.457.
15. Murray P. Washington, DC; U.S. Senate Health, Education, Labor, and Pensions Committee; 2016. Preventable tragedies: superbugs and how ineffective monitoring of medical device safety fails patients; 2016. Available on: https://psnet. ahrq.gov/issue/preventable-tragedies-superbugsand-how-ineffective-monitoring-medical-device-safety-fails [Last accessed: 2022 Apr 7].
16. Smith Z, Young S, Saeian K. Transmission of carbapenem-resistant Enterobacteriaceae during ERCP: time to revisit the current reprocessing guidelines. Gastrointest Endosc. 2015; 81(4): 1041-5. doi: 10.1016/j.gie.2014.11.006. Epub 2015 Jan 28.
17. Epstein L, Hunter J, Arwady M. New Delhi me tallo-beta-lactamase producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes. JAMA. 2014 Oct 8; 312(14): 1447-55. doi: 10.1001/jama.2014.12720.
18. Larsen S, Russell RV, Ockert LK, et al. Rate and impact of duodenoscope contamination: A systematic review and meta-analysis. EClinicalMedicine. 2020 Jul 15; 25: 100451. doi: 10.1016/j.eclinm.2020.100451.
19. Thaker AM, Muthusamy VR, Sedarat A, et al. Duodenoscope reprocessing practice patterns in U.S. endoscopy centers: a survey study.
2018 Aug; 88(2): 316-322.e2. doi: 10.1016/j. gie.2018.04.2340. Epub 2018 Apr 21.
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.